DEUTSCHE BANK AG\
BankPosition in KYMR — Kymera Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in KYMR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,160,638
+$4,507,788 QoQ
Shares Held
106,049
+15.4% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. KYMR ranks #37 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,160,638 | 106,049 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $7,652,850 | 91,882 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $6,212,583 | 79,843 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,116,913 | 72,737 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,221,930 | 50,915 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,478,170 | 54,007 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,914,341 | 72,442 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,069,077 | 43,716 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $1,081,554 | 36,233 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,683,414 | 41,876 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $510,930 | 20,068 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $276,387 | 19,884 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $402,186 | 17,494 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $746,705 | 25,201 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $523,685 | 20,981 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $347,797 | 15,976 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $397,264 | 20,176 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,412,048 | 33,366 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,250,719 | 35,450 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,092,259 | 35,619 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $926,349 | 19,100 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $264,169 | 6,798 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $459,420 | 7,410 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||